{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:21:31Z","timestamp":1789176091043,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Postgraduate research and innovation projects of Chongqing Municipal Education Commission","award":["CYB240211"],"award-info":[{"award-number":["CYB240211"]}]},{"name":"The Postgraduate research and innovation projects of Chongqing Municipal Education Commission","award":["CYB240211"],"award-info":[{"award-number":["CYB240211"]}]},{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81970571"],"award-info":[{"award-number":["81970571"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Program for Youth Innovation in Future Medicine at Chongqing Medical University","award":["3001112"],"award-info":[{"award-number":["3001112"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-024-05296-4","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T15:05:21Z","timestamp":1729609521000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of high-dose vitamin D supplementation vs. solifenacin or standard urotherapy for overactive bladder dry in children: a secondary analysis of a randomized clinical trial"],"prefix":"10.1007","volume":"42","author":[{"given":"Hongsong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhicheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenmin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9249-1366","authenticated-orcid":false,"given":"Xing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Guanghui Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,22]]},"reference":[{"issue":"9","key":"5296_CR1","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/nrurol.2016.152","volume":"13","author":"I Franco","year":"2016","unstructured":"Franco I (2016) Overactive bladder in children. Nat Rev Urol 13(9):520\u2013532. https:\/\/doi.org\/10.1038\/nrurol.2016.152","journal-title":"Nat Rev Urol"},{"key":"5296_CR2","doi-asserted-by":"publisher","unstructured":"Chung JM, Lee SD, Kang DI, Kwon DD, Kim KS, Kim SY, Kim HG, Moon DG, Park KH, Park YH, Pai KS, Suh HJ, Lee JW, Cho WY, Ha TS, Han SW (2009) Prevalence and associated factors of overactive bladder in Korean children 5\u201313 years old: a nationwide multicenter study. Urology 73(1) 63\u2009\u2013\u20097; discussion 68\u2009\u2013\u20099. https:\/\/doi.org\/10.1016\/j.urology.2008.06.063","DOI":"10.1016\/j.urology.2008.06.063"},{"issue":"9","key":"5296_CR3","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s11255-019-02209-y","volume":"51","author":"JW Noh","year":"2019","unstructured":"Noh JW, Lee B, Kim JH (2019) Efficacy and safety of anticholinergics for children or adolescents with idiopathic overactive bladder: systematic review and meta-analysis. Int Urol Nephrol 51(9):1459\u20131471. https:\/\/doi.org\/10.1007\/s11255-019-02209-y","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"5296_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jpurol.2022.09.014","volume":"19","author":"G Raman","year":"2023","unstructured":"Raman G, Tunnicliffe D, Lai E, Bennett T, Caldwell P (2023) Safety and tolerability of solifenacin in children and adolescents with overactive bladder- a systematic review. J Pediatr Urol 19(1):19.e1-19.e13. https:\/\/doi.org\/10.1016\/j.jpurol.2022.09.014","journal-title":"J Pediatr Urol"},{"issue":"6","key":"5296_CR5","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1097\/JU.0000000000001441","volume":"205","author":"P Yuan","year":"2021","unstructured":"Yuan P, Wang T, Li H, Lan R, Li M, Liu J (2021) Systematic Review and Meta-analysis of the association between Vitamin D Status and lower urinary tract symptoms. J Urol 205(6):1584\u20131594. https:\/\/doi.org\/10.1097\/JU.0000000000001441","journal-title":"J Urol"},{"issue":"5","key":"5296_CR6","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s00192-021-04963-z","volume":"33","author":"R Baer","year":"2022","unstructured":"Baer R, Tene L, Weintraub AY, Kalichman L (2022) The effect of vitamin D deficiency and supplementation on urinary incontinence: scoping review. Int Urogynecol J 33(5):1083\u20131090. https:\/\/doi.org\/10.1007\/s00192-021-04963-z","journal-title":"Int Urogynecol J"},{"issue":"1","key":"5296_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/JU.0000000000003763","volume":"211","author":"H Chen","year":"2024","unstructured":"Chen H, Zhang Z, Wu S, Zhang D, Zhong X, Liu X, Wei G (2024) Efficacy and safety of high-dose vitamin D supplementation vs solifenacin or standard urotherapy for overactive bladder dry in children: a Randomized Clinical Trial. J Urol 211(1):26\u201336. https:\/\/doi.org\/10.1097\/JU.0000000000003763","journal-title":"J Urol"},{"issue":"8","key":"5296_CR8","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/nrendo.2017.31","volume":"13","author":"R Bouillon","year":"2017","unstructured":"Bouillon R (2017) Comparative analysis of nutritional guidelines for vitamin D. Nat Rev Endocrinol 13(8):466\u2013479. https:\/\/doi.org\/10.1038\/nrendo.2017.31","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"5296_CR9","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1371\/journal.pmed.0050045","volume":"5","author":"I Kirsch","year":"2008","unstructured":"Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT (2008) Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. Plos Med 5(2):e45. https:\/\/doi.org\/10.1371\/journal.pmed.0050045","journal-title":"Plos Med"},{"issue":"1","key":"5296_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/jama.2009.1943","volume":"303","author":"JC Fournier","year":"2010","unstructured":"Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, Fawcett J (2010) Antidepressant drug effects and depression severity: a patient-level meta-analysis. Jama-J Am Med Assoc 303(1):47\u201353. https:\/\/doi.org\/10.1001\/jama.2009.1943","journal-title":"Jama-J Am Med Assoc"},{"issue":"8","key":"5296_CR11","doi-asserted-by":"publisher","first-page":"e13145","DOI":"10.1111\/eci.13145","volume":"49","author":"M Brankovic","year":"2019","unstructured":"Brankovic M, Kardys I, Steyerberg EW, Lemeshow S, Markovic M, Rizopoulos D, Boersma E (2019) Understanding of interaction (subgroup) analysis in clinical trials. Eur J Clin Invest 49(8):e13145. https:\/\/doi.org\/10.1111\/eci.13145","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"5296_CR12","doi-asserted-by":"publisher","first-page":"535e1","DOI":"10.1016\/j.ajog.2021.10.017","volume":"226","author":"AD Markland","year":"2022","unstructured":"Markland AD, Vaughan C, Huang A, Kim E, Bubes VY, Tangpricha V, Buring J, Lee IM, Cook N, Manson JE, Grodstein F (2022) Effect of vitamin D supplementation on urinary incontinence in older women: ancillary findings from a randomized trial. Am J Obstet Gynecol 226(4):535e1\u2013535e12. https:\/\/doi.org\/10.1016\/j.ajog.2021.10.017","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"5296_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/JU.0000000000002942","volume":"209","author":"AD Markland","year":"2023","unstructured":"Markland AD, Vaughan CP, Huang AJ, Kim E, Bubes VY, Tangpricha V, Buring JR, Lee IM, Cook NR, Manson JE, Grodstein F (2023) Effect of vitamin D supplementation on overactive bladder and urinary incontinence symptoms in older men: ancillary findings from a Randomized Trial. J Urol 209(1):243\u2013252. https:\/\/doi.org\/10.1097\/JU.0000000000002942","journal-title":"J Urol"},{"issue":"2","key":"5296_CR14","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1590\/S1677-5538.IBJU.2021.0645","volume":"48","author":"B Ozcift","year":"2022","unstructured":"Ozcift B, Micoogullari U (2022) The effect of vitamin D deficiency in children with overactive bladder related urinary incontinence. Int Braz J Urol 48(2):316\u2013325. https:\/\/doi.org\/10.1590\/S1677-5538.IBJU.2021.0645","journal-title":"Int Braz J Urol"},{"issue":"6","key":"5296_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2165\/00148581-200709060-00005","volume":"9","author":"I Franco","year":"2007","unstructured":"Franco I (2007) Pediatric overactive bladder syndrome: pathophysiology and management. Pediatr Drugs 9(6):379\u2013390. https:\/\/doi.org\/10.2165\/00148581-200709060-00005","journal-title":"Pediatr Drugs"},{"issue":"6","key":"5296_CR16","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1016\/j.juro.2009.08.039","volume":"182","author":"JG Blaivas","year":"2009","unstructured":"Blaivas JG, Marks BK, Weiss JP, Panagopoulos G, Somaroo C (2009) Differential diagnosis of overactive bladder in men. J Urol 182(6):2814\u20132817. https:\/\/doi.org\/10.1016\/j.juro.2009.08.039","journal-title":"J Urol"},{"issue":"6","key":"5296_CR17","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.eururo.2019.02.038","volume":"75","author":"B Peyronnet","year":"2019","unstructured":"Peyronnet B, Mironska E, Chapple C, Cardozo L, Oelke M, Dmochowski R, Amarenco G, Game X, Kirby R, Van Der Aa F, Cornu JN (2019) A Comprehensive Review of overactive bladder pathophysiology: on the way to tailored treatment. Eur Urol 75(6):988\u20131000. https:\/\/doi.org\/10.1016\/j.eururo.2019.02.038","journal-title":"Eur Urol"},{"issue":"3","key":"5296_CR18","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/jgs.15711","volume":"67","author":"AD Markland","year":"2019","unstructured":"Markland AD, Tangpricha V, Mark BT, Vaughan CP, Richter HE, Burgio KL, Goode PS (2019) Comparing vitamin D supplementation Versus Placebo for urgency urinary incontinence: a pilot study. J Am Geriatr Soc 67(3):570\u2013575. https:\/\/doi.org\/10.1111\/jgs.15711","journal-title":"J Am Geriatr Soc"},{"issue":"8","key":"5296_CR19","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1007\/s00192-023-05486-5","volume":"34","author":"M Arjmand","year":"2023","unstructured":"Arjmand M, Abbasi H, Behforouz A (2023) The effect of vitamin D on urgent urinary incontinence in postmenopausal women. Int Urogynecol J 34(8):1955\u20131960. https:\/\/doi.org\/10.1007\/s00192-023-05486-5","journal-title":"Int Urogynecol J"},{"issue":"3","key":"5296_CR20","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00345-020-03257-1","volume":"39","author":"JW Kim","year":"2021","unstructured":"Kim JW, Ahn HK, Ko J, Lee D, Ha JS, Kim JH, Park SJ, Cho KS (2021) Seasonal variations in overactive bladder drug prescription rates in women: a nationwide population-based study. World J Urol 39(3):877\u2013882. https:\/\/doi.org\/10.1007\/s00345-020-03257-1","journal-title":"World J Urol"},{"issue":"5","key":"5296_CR21","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.euf.2020.10.010","volume":"7","author":"H Mostafaei","year":"2021","unstructured":"Mostafaei H, Mori K, Quhal F, Miura N, Motlagh RS, Pradere B, Laukhtina E, Lysenko I, Ghaffari S, Hajebrahimi S, Shariat SF (2021) Nocebo Response in the Pharmacological Management of overactive bladder: a systematic review and Meta-analysis. Eur Urol Focus 7(5):1143\u20131156. https:\/\/doi.org\/10.1016\/j.euf.2020.10.010","journal-title":"Eur Urol Focus"},{"issue":"3","key":"5296_CR22","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1097\/01.ju.0000152183.91888.f6","volume":"173","author":"C Akbal","year":"2005","unstructured":"Akbal C, Genc Y, Burgu B, Ozden E, Tekgul S (2005) Dysfunctional voiding and incontinence scoring system: quantitative evaluation of incontinence symptoms in pediatric population. J Urol 173(3):969\u2013973. https:\/\/doi.org\/10.1097\/01.ju.0000152183.91888.f6","journal-title":"J Urol"},{"issue":"3","key":"5296_CR23","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.eururo.2016.08.061","volume":"71","author":"D Newgreen","year":"2017","unstructured":"Newgreen D, Bosman B, Hollestein-Havelaar A, Dahler E, Besuyen R, Sawyer W, Bolduc S, Rittig S (2017) Solifenacin in children and adolescents with overactive bladder: results of a phase 3 Randomised Clinical Trial. Eur Urol 71(3):483\u2013490. https:\/\/doi.org\/10.1016\/j.eururo.2016.08.061","journal-title":"Eur Urol"},{"issue":"4","key":"5296_CR24","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.juro.2017.05.038","volume":"198","author":"D Newgreen","year":"2017","unstructured":"Newgreen D, Bosman B, Hollestein-Havelaar A, Dahler E, Besuyen R, Snijder R, Sawyer W, Rittig S, Bolduc S (2017) Long-term safety and efficacy of Solifenacin in Children and adolescents with overactive bladder. J Urol 198(4):928\u2013936. https:\/\/doi.org\/10.1016\/j.juro.2017.05.038","journal-title":"J Urol"},{"issue":"3","key":"5296_CR25","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1001\/jamainternmed.2019.6398","volume":"180","author":"KL Burgio","year":"2020","unstructured":"Burgio KL, Kraus SR, Johnson TN, Markland AD, Vaughan CP, Li P, Redden DT, Goode PS (2020) Effectiveness of combined behavioral and drug therapy for overactive bladder symptoms in men: a Randomized Clinical Trial. Jama Intern Med 180(3):411\u2013419. https:\/\/doi.org\/10.1001\/jamainternmed.2019.6398","journal-title":"Jama Intern Med"},{"issue":"1","key":"5296_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1464-410X.2007.06517.x","volume":"99","author":"CK Payne","year":"2007","unstructured":"Payne CK, Kelleher C (2007) Redefining response in overactive bladder syndrome. Bju Int 99(1):101\u2013106. https:\/\/doi.org\/10.1111\/j.1464-410X.2007.06517.x","journal-title":"Bju Int"},{"issue":"5","key":"5296_CR27","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.eururo.2016.04.033","volume":"70","author":"CR Chapple","year":"2016","unstructured":"Chapple CR, Kelleher CJ, Evans CJ, Kopp Z, Siddiqui E, Johnson N, Mako M (2016) A narrative review of patient-reported outcomes in overactive bladder: what is the way of the future? Eur Urol 70(5):799\u2013805. https:\/\/doi.org\/10.1016\/j.eururo.2016.04.033","journal-title":"Eur Urol"},{"issue":"2","key":"5296_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jpsychores.2014.11.019","volume":"78","author":"D Vrijens","year":"2015","unstructured":"Vrijens D, Drossaerts J, van Koeveringe G, Van Kerrebroeck P, van Os J, Leue C (2015) Affective symptoms and the overactive bladder - a systematic review. J Psychosom Res 78(2):95\u2013108. https:\/\/doi.org\/10.1016\/j.jpsychores.2014.11.019","journal-title":"J Psychosom Res"},{"issue":"3","key":"5296_CR29","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.juro.2013.02.037","volume":"190","author":"PK Sand","year":"2013","unstructured":"Sand PK, Dmochowski RR, Reddy J, van der Meulen EA (2013) Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study. J Urol 190(3):958\u2013964. https:\/\/doi.org\/10.1016\/j.juro.2013.02.037","journal-title":"J Urol"},{"issue":"9","key":"5296_CR30","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nrurol.2011.99","volume":"8","author":"A Mangera","year":"2011","unstructured":"Mangera A, Chapple CR, Kopp ZS, Plested M (2011) The placebo effect in overactive bladder syndrome. Nat Rev Urol 8(9):495\u2013503. https:\/\/doi.org\/10.1038\/nrurol.2011.99","journal-title":"Nat Rev Urol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-024-05296-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-024-05296-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-024-05296-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T21:24:35Z","timestamp":1735853075000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-024-05296-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,22]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5296"],"URL":"https:\/\/doi.org\/10.1007\/s00345-024-05296-4","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,22]]},"assertion":[{"value":"8 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"586"}}